Physician

James R Mulinda, M.D.

According to 2025 Medicare claims, James Mulinda, M.D. (NPI: 1093797094) practices internal medicine in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is ENDOCRINOLOGY ASSOCIATES INC (NPI: 1275613473; TIN: 541915570) and primary practice location at 24018-3752. Mulinda is affiliated with the Doctors Connected (ACO ID: A4949), participating under the MSSP model.

Mulinda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,252 traditional Medicare patients, billed 25,661 HCPCS/CPT codes, and received $565,802 in Medicare payments. The top billing code was 84443 (Blood test, thyroid stimulating hormone (tsh)). Part D data shows 11,757 prescription claims across 1,399 beneficiaries totaling $5,473,121 in drug costs, led by Jardiance (Empagliflozin). DME data shows 1,992 claims. Open Payments data shows 311 records totaling $76,201. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $462,090 and ending at $565,802. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,760,396 to $5,473,121. For DME billing, reported payments moved sharply higher in recent years, from $24,145 to $498,861.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,039	62,542	$462,090
2016	1,109	63,453	$558,419
2017	1,130	59,537	$672,841
2018	1,209	64,481	$773,006
2019	1,157	44,491	$558,878
2020	1,035	23,838	$413,167
2021	974	19,420	$435,608
2022	912	17,018	$385,091
2023	1,131	23,938	$559,078
2024	1,252	25,661	$565,802

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	626	6,822	$1,760,396
2016	676	7,406	$2,095,652
2017	705	7,666	$2,526,488
2018	791	7,960	$2,837,941
2019	848	8,130	$3,282,529
2020	862	8,341	$3,538,889
2021	886	8,693	$4,137,457
2022	861	8,660	$4,658,196
2023	1,066	10,065	$5,962,582
2024	1,399	11,757	$5,473,121

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	605	1,460	$47,763
2016	590	1,404	$42,138
2017	375	900	$25,215
2018	506	1,315	$82,422
2019	475	1,485	$147,670
2020	449	1,518	$170,681
2021	387	1,553	$201,408
2022	316	1,367	$202,417
2023	476	1,964	$360,000
2024	535	1,992	$529,348

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
84443	Blood test, thyroid stimulating hormone (tsh)	980	1,981	$16
84439	Thyroxine (thyroid chemical), free	943	1,897	$9
36415	Insertion of needle into vein for collection of blood sample	1,016	2,098	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	1,007	2,031	$8
80076	Liver function blood test panel	964	1,915	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	781	43,280	$838,438
Ozempic	Semaglutide	523	22,851	$748,593
Trulicity	Dulaglutide	421	19,199	$647,526
Mounjaro	Tirzepatide	335	13,262	$478,075
Farxiga	Dapagliflozin Propanediol	238	15,490	$286,646

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	231	1,217	$402,591
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	20	80	$30,718
E0784	External ambulatory infusion pump, insulin	Y	13	87	$28,941
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	42	109	$28,007
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	26	$13,667

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	311	$76,201	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James R. Mulinda, M.D.?

Tedicare shows public-source Medicare data for James R. Mulinda, M.D. (NPI 1093797094), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James R. Mulinda, M.D. have ACO affiliation data?

James R. Mulinda, M.D. is shown with ACO affiliation data for Doctors Connected (MSSP, ACO ID A4949).

What billing organization is linked to James R. Mulinda, M.D.?

James R. Mulinda, M.D. is linked to ENDOCRINOLOGY ASSOCIATES INC (billing NPI 1275613473) in the available physician profile data.

Does James R. Mulinda, M.D. have Open Payments data?

James R. Mulinda, M.D. has 311 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.